Axonal damage markers in cerebrospinal fluid are increased in ALS

被引:217
作者
Brettschneider, J
Petzold, A
Süssmuth, SD
Ludolph, AC
Tumani, H
机构
[1] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany
[2] Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England
关键词
D O I
10.1212/01.wnl.0000203120.85850.54
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To test whether biomarkers for axonal degeneration correlated with clinical subtypes and were of use in predicting progression of ALS. Methods: Patients with ALS (n = 69), patients with Alzheimer disease (AD; n = 73), and age-matched controls (n = 33) were included in this prospective study. CSF levels of tau protein and neurofilaments (NfH(SMI35)) were measured using ELISA. In 49 patients with ALS, follow-up data were available (median follow-up 7 months). Results: CSF levels of NfHSMI35 were five times higher in patients with ALS (1.7 ng/mL) than in controls (0.3 ng/mL, p < 0.001) and 10 times higher than in patients with AD (0.14 ng/mL, p < 0.001). NfH(SMI35) values were also higher in patients with upper motor neuron-dominant ALS than in patients with typical ALS (upper motor neuron + lower motor neuron) at p = 0.02. Values of NfH(SMI35) were higher in ALS of more rapid progression. The values of NfH and tau did not correlate with CSF protein content. Conclusions: The authors propose that axonal damage markers in CSF may discriminate between subtypes of ALS and that they could be used as markers for therapeutic trials. CSF NfH was superior to tau in these discriminations.
引用
收藏
页码:852 / 856
页数:5
相关论文
共 34 条
[1]  
*ACTS PHASE 1 2 ST, 1996, ARCH NEUROL-CHICAGO, V563, P141
[2]  
BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371
[3]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[4]   DEFECTIVE AXONAL-TRANSPORT IN A TRANSGENIC MOUSE MODEL OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].
COLLARD, JF ;
COTE, F ;
JULIEN, JP .
NATURE, 1995, 375 (6526) :61-64
[5]   Motor responses evoked by transcranial magnetic stimulation and peripheral nerve stimulation in the ulnar innervation in amyotrophic lateral sclerosis: the effect of upper and lower motor neuron lesion [J].
de Carvalho, M ;
Turkman, A ;
Swash, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 210 (1-2) :83-90
[6]   PHOSPHORYLATION PROTECTS NEUROFILAMENTS AGAINST PROTEOLYSIS [J].
GOLDSTEIN, ME ;
STERNBERGER, NH ;
STERNBERGER, LA .
JOURNAL OF NEUROIMMUNOLOGY, 1987, 14 (02) :149-160
[7]   Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis [J].
Jiménez-Jiménez, FJ ;
Hernánz, A ;
Medina-Acebrón, S ;
de Bustos, F ;
Zurdo, JM ;
Alonso, H ;
Puertas, I ;
Barcenilla, B ;
Sayed, Y ;
Cabrera-Valdivia, F .
ACTA NEUROLOGICA SCANDINAVICA, 2005, 111 (02) :114-117
[8]   Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? [J].
Julien, JP ;
Beaulieu, JM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 180 (1-2) :7-14
[9]   Increased cerebrospinal fluid tau protein in multiple sclerosis [J].
Kapaki, E ;
Paraskevas, GP ;
Michalopoulou, M ;
Kilidireas, K .
EUROPEAN NEUROLOGY, 2000, 43 (04) :228-232
[10]  
KATO S, 2003, MOL PATHOLOGY DEMENT